This cross-sectional study included 202 patients with AIS, 41 patients with ICH, and 253 healthy individuals and investigated the relationships between serum β2M levels and the prevalence of acute cerebral infarction, the severity of infarction (NIHSS score), the subtypes of AIS, and the risk of recurrent stroke (ESRS). The gene discussed is B2M; the disease is infarction.